Long-term results of a phase II randomized controlled trial (RCT) of a psychological intervention (Conquer Fear) to reduce clinical levels of fear of cancer recurrence in breast, colorectal, and melanoma cancer survivors.
The DOI matches its Crossref record.
Abstract
LBA10000 Background: Up to 70% of cancer survivors report clinically significant fear of cancer recurrence (FCR). This parallel RCT evaluated the impact of a psychological intervention, Conquer Fear (CF), on FCR in cancer survivors. Methods: Participants were disease-free stage I-III breast, colorectal or melanoma cancer survivors, 2 months to 5 years post-treatment, who scored above the clinical cut-off (≥13) on the FCR Inventory (FCRI) severity subscale. CF included 5 sessions incorporating attention training, detached mindfulness, challenging unhelpful metacognitions, values clarification and psycho-education. Participants were randomised to the intervention ( n= 121) or a relaxation training (RT) control arm ( n= 101) (target n= 260). The primary end-point was reduction in FCR (FCRI total) immediately after intervention completion. Follow-up assessments occurred immediately, 3- and 6-months post-treatment. Data analysis was by intention to treat. The differences in change in FCR from baseline between CF and RT and secondary outcomes were tested using independent t-tests. A difference of 14.5 points in FCR was considered clinically significant. Long-term changes in FCR and secondary outcomes were evaluated using linear regression models fitted with generalized estimating equations (GEE), adjusted for baseline FCR. Results: Reduction in FCR between baseline and immediately post-treatment was significantly more in CF participants compared to RT. (Difference in change (95% CI): -10.5 (-16.1, -4.9); p < 0.001). Greater FCR reductions were also observed amongst CF participants at 3 months (-7.6 (-13.9, -1.4), p = 0.02) and 6 months (-7.8 (-14.2, -1.4), p = 0.02) compared with RT. The pattern of change in outcomes over time was consistent between treatment groups as no significant linear trends in treatment effects over time were observed. Conclusions: Conquer Fear is a theoretically-grounded intervention to reduce FCR and its associated psychological morbidity which leads to significantly greater reductions in FCR in the first 6 months following treatment than relaxation training. Clinical trial information: ACTRN12612000404820.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“randomized trials have shown that they significantly reduce fear of cancer recurrence relative to usual care [33], relaxation training [34], and supportive-expressive group therapy [29, 31].”
Citations
Cites
Still being checked.
Cited by
Caregiver fear of cancer recurrence: A systematic review and meta‐analysis of quantitative studies
Webb, K., Sharpe, L., Butow, P. N., Dhillon, H. M., Zachariae, R. H., Tauber, N. M., O’Toole, M. S., & Shaw, J. (2023) · Psycho-Oncology · doi:10.1002/pon.6176 · Cited by 53
Self-citationSansom‐Daly, U. M., Wakefield, C. E., Robertson, E. G., McGill, B. C., Wilson, H. L., & Bryant, R. A. (2018) · Psycho-Oncology · doi:10.1002/pon.4856 · Cited by 39
Nieto, M., Bravo, B. N., Moreno, B., Ocaña, A., Serrano, J. P., Gras, C. B., Ricarte, J. J., Fernández‐Aguilar, L., Ros, L., & Latorre, J. M. (2019) · PeerJ · doi:10.7717/peerj.8126 · Cited by 23
Arch, J. J., Mitchell, J. L., Genung, S. R., Fisher, R., Andorsky, D. J., & Stanton, A. L. (2019) · BMC Cancer · doi:10.1186/s12885-019-5289-x · Cited by 20
“The danger still hangs over my head” Fear of Recurrence among Israeli Breast Cancer Survivors
Levkovich, I. (2019) · Journal of Health Sciences · doi:10.17532/jhsci.2019.687 · Cited by 5
Metadata
- Authors
- Beith, J. M., Thewes, B., Turner, J., Gilchrist, J., Sharpe, L., Girgis, A., Smith, A. '., Fardell, J., Tesson, S., O'Connell, R., Asher, R., Butow, P., & Members of the Conquer Fear Authorship Group
- Affiliations
- Chris O’Brien Lifehouse (AU)
- The University of Sydney (AU)
- The University of Queensland (AU)
- Westmead Hospital (AU)
- Centre for Oncology Education and Research Translation (CONCERT), Sydney, Australia;
- UNSW Sydney (AU)
- NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia;
- ORCID
- Venue
- Journal of Clinical Oncology
- Published
- 2017-06-20
- Volume
- 35
- Issue
- 18_suppl
- Pages
- LBA10000-LBA10000
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2625411172
- Cited by
- 7
- References
- 0
- Citations by year
- 2023: 1 · 2019: 3 · 2018: 2 · 2017: 1
- Type
- conference abstract
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Oncology (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- fear of cancer recurrence, cancer survivors, detached mindfulness, metacognition, attention training, values clarification, relaxation training, breast cancer, colorectal cancer, melanoma, long-term outcomes, psychological intervention, psychoeducation, treatment effects over time, intention-to-treat analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term results of a phase II randomized controlled trial (RCT) of a psychological intervention (Conquer Fear) to reduce clinical levels of fear of cancer recurrence in breast, colorectal, and melanoma cancer survivors. https://app.cochat.ai/papers/10.1200/jco.2017.35.18_suppl.lba10000
- The paper
- Beith, J. M., Thewes, B., Turner, J., Gilchrist, J., Sharpe, L., Girgis, A., Smith, A. '., Fardell, J., Tesson, S., O'Connell, R., Asher, R., Butow, P., & Members of the Conquer Fear Authorship Group. (2017). Long-term results of a phase II randomized controlled trial (RCT) of a psychological intervention (Conquer Fear) to reduce clinical levels of fear of cancer recurrence in breast, colorectal, and melanoma cancer survivors. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2017.35.18_suppl.lba10000
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.